In a lipopolysaccharide (LPS)-induced PD model, C18-GM3 was shown to engage the TLR4-driven inflammatory cascade, ultimately protecting dopaminergic terminals and improving motor deficits (46). The gene discussed is TLR4; the disease is Parkinson disease.